HealthKit won't tangle with the FDA

Share this article:

Apple's HealthKit will not have to get the FDA's approval. MobiHealth News reports that the new health tool is benefiting from the FDA's June 11 announcement in which it specified the types of mobile health apps that can go live without courting regulatory approval.

These apps include vaccination records, drug interaction apps and apps that allow “a user to collect, log, track and trend data such as blood glucose, blood pressure, heart rate, weight or other data” that can be shared with an HCP or transferred to an EHR.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.